Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramatroban in Hospitalized COVID-19 Patients
NCT05706454Phase 3Recruiting
- Sponsor
- KARE Biosciences
- Start
- Nov 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramatroban in COVID-19 pneumonia, sponsored by KARE Biosciences. Started Nov 2022; status: recruiting.
02
Drugs
ramatroban
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05706454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706454.